CoChat

Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal disease, and therapeutic agents have shown only modest efficacy. Epigenetic alterations contribute to the pathogenesis of IPF. The histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), has been approved for clinical use in cancer; however, its potential efficacy in modulating fibroblast survival and lung fibrosis has not been extensively investigated. We investigated the effects of SAHA on apoptosis of primary IPF myofibroblasts and on injury-induced lung fibrosis in a murine model. SAHA-induced apoptosis of IPF myofibroblasts, an effect that was mediated, at least in part, by upregulation of the pro-apoptotic gene Bak and downregulation of the anti-apoptotic gene Bcl-xL. Alterations in the expression of these apoptosis-related genes were associated with histone modifications and changes in DNA methylation. In addition to the expected higher levels of histone acetylation in treated cells, we also detected changes in other histone modifications, such as histone methylation. In a murine model of bleomycin-induced pulmonary fibrosis, SAHA-treated mice displayed decreased lung fibrosis and improved lung function compared to the bleomycin only group. These results suggest that histone deacetylase inhibitors may offer a new therapeutic strategy in IPF by modulating myofibroblast susceptibility to apoptosis.

Overview

Integrity signals

Registry

Crossref · 10.1183/09031936.00095113

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 38 · Cited by 167

Metadata

Authors
Sanders, Y. Y., Hagood, J. S., Liu, H., Zhang, W., Ambalavanan, N., & Thannickal, V. J.
Affiliations
  • University of Alabama at Birmingham (US)
  • University of California San Diego (US)
Venue
European Respiratory Journal
Published
2014-03-06
Volume
43
Issue
5
Pages
1448-1458
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2140928316
Cited by
167
References
38
Citations by year
2026: 17 · 2025: 14 · 2024: 17 · 2023: 12 · 2022: 11 · 2021: 17 · 2020: 16 · 2019: 11 · 2018: 8 · 2017: 14 · 2016: 11 · 2015: 15 · 2014: 4
FWCI
11.75
Type
journal article
Language
en
Open access
closed
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL082818, HL092906, HL082818, R01HL092906, P50HL107181, HL14470, R01HL067967)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
idiopathic pulmonary fibrosis, histone deacetylase inhibition, vorinostat, myofibroblast apoptosis, fibroblast survival, Bak, Bcl-xL, histone modifications, DNA methylation, histone acetylation, histone methylation, bleomycin-induced lung fibrosis, epigenetic therapy
MeSH terms
Vorinostat, Animals, Bleomycin, Cell Survival, Fibroblasts, Histone Deacetylases, Histones, Humans, Hydroxamic Acids, Lung, Mice, Inbred C57BL, Apoptosis, DNA Methylation, Cell Proliferation, Mice, Idiopathic Pulmonary Fibrosis, Histone Deacetylase Inhibitors, Myofibroblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. https://app.cochat.ai/papers/10.1183/09031936.00095113
The paper
Sanders, Y. Y., Hagood, J. S., Liu, H., Zhang, W., Ambalavanan, N., & Thannickal, V. J. (2014). Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. European Respiratory Journal. https://doi.org/10.1183/09031936.00095113

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.